Ma et al. [59] reported that NOD2 deficiency promoted hepatocarcinogenesis, while overexpression of NOD2 in HCC cells inhibited tumorigenesis and reversed resistance to chemotherapy. Here, NOD2 is linked to hepatocellular carcinoma.